Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
58 hedge funds and large institutions have $18.1M invested in Genesis Healthcare, Inc. in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 25 closing their positions.
13% less funds holding
Funds holding: 67 → 58 (-9)
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
36% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 25
38% less capital invested
Capital invested by funds: $29.1M → $18.1M (-$11M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.32M |
| 2 |
Jane Street
New York
|
+$284K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$214K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$162K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$156K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.2M |
| 2 |
VCM
V3 Capital Management
Dallas,
Texas
|
-$1.43M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.01M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$703K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$696K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACA
76
Aptus Capital Advisors
Fairhope,
Alabama
| – | -$10K | -12,300 | Closed |
|
77
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$10K | -12,230 | Closed |
|
|
ASN
78
Advisory Services Network
Atlanta,
Georgia
| – | -$6K | -7,713 | Closed |
|
|
AIP
79
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$6K | -7,358 | Closed |
|
80
Simplex Trading
Chicago,
Illinois
| – | +$117 | +145 | +382% |
|
|
SIAP
81
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
| – | +$241 | +300 | New |
|
GEN Hedge Fund Activity: Q2 2020 in Review
58 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q2 2020, worth a combined $18.1M — down 38% from $29.1M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of GEN and 16 opened new positions — a net loss of 9 holders — while 17 trimmed existing stakes and 11 added.
The largest buyer was Vanguard Group, adding an estimated $1.32M. The largest seller was BlackRock, cutting an estimated $3.2M.
- 58 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q2 2020, down from 67 in Q1 2020.
- Funds reported $18.1M of Genesis Healthcare, Inc. stock for Q2 2020, down 38% quarter-over-quarter.
- 16 funds opened new Genesis Healthcare, Inc. positions in Q2 2020 and 25 closed out, a net change of -9 holders.
- The largest Genesis Healthcare, Inc. buyer in Q2 2020 was Vanguard Group, an estimated $1.32M added.
- The largest Genesis Healthcare, Inc. seller in Q2 2020 was BlackRock, an estimated $3.2M sold.
Based on aggregated 13F filings for Q2 2020.